`IPR2023-00512
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________________________________
`
`
`APOTEX INC.
`Petitioner
`
`v.
`
`CELGENE CORPORATION
`Patent Owner
`
`____________________________________________
`Case IPR2023-00512
`U.S. Patent No. 8,846,628 B2
`
`____________________________________________
`
`
`PATENT OWNER’S POWER OF ATTORNEY
`UNDER 37 C.F.R. § 42.10
`
`
`
`
`
`Celgene Corporation Power of Attorney
`IPR2023-00512
`
`
`Patent Owner, Celgene Corporation, hereby appoints the following attorneys
`
`
`
`
`and/or agents to prosecute the captioned Inter Partes Review proceedings and
`
`transact all business in the U.S. Patent and Trademark Office connected therewith:
`
`(cid:120) All practitioners at Customer Number 24395
`
`(cid:120) All attorneys at Wilmer Cutler Pickering Hale and Dorr LLP
`for whom a motion to appear pro hac vice is filed.
`Please address all communications to:
`
`Wilmer Cutler Pickering Hale and Dorr LLP
`2100 Pennsylvania Avenue N.W.
`Washington, DC 20037
`Telephone: 202-663-6000
`Facsimile: 202-663-6363
`Please address all e-mails and telephone calls to lead and back-up counsel, who are
`
`identified in Patent Owner’s Mandatory Notices.
`
`1
`
`
`
`
`The individual listed below has the authority to execute this document on behalf of
`
`Celgene Corporation Power of Attorney
`IPR2023-00512
`
`
`Celgene Corporation.
`
`
`
`
`
`
`
`
`
`
`For: Celgene Corporation
`
`
`
`
`Name: J. Patrick Elsevier
`
`Title: Senior Vice President
`
`
` Bristol Myers Squibb
`
` (Authorized Signatory)
`
`
`
`Date: 2/27/2023
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`